e-Drug3D 1477 |
ASENAPINE
|
cas 65576-45-6 |
CLASS ANTIPSYCHOTICS |
ROUTE (list) SUBLINGUAL TRANSDERMAL |
ATC code |
PK parameters F 35 PERCENT (5 MILLIGRAM) |
Target TARGET 5-HT2A RECEPTOR (KI = 0.06 NANOMOLAR) |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A |
Download SDF file | 1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, 5-chloro-2,3,3a,12b-tetrahydro-2-methyl-, (3aR,12bR)-rel- Formula: Calculated chemical properties: MW 285.76 NB_atoms 20 XLogP 4.26 PSA 15.235 NB_HD 0 NB_HA 2 fsp3 0.29 Lipinski(0=no;1=yes) 1 |
FDA NDA 022117 (label) INN (ASENAPINE MALEATE) SAPHRIS (ALLERGAN) APPROVAL= AP YEAR= 2009 NDA 212268 (label) INN (ASENAPINE) SECUADO (HISAMITSU) APPROVAL= AP YEAR= 2019 NDA 206098 (pdf not found) INN (ASENAPINE MALEATE) ASENAPINE MALEATE (ALEMBIC) APPROVAL= AP YEAR= 2020 NDA 206107 (pdf not found) INN (ASENAPINE MALEATE) ASENAPINE MALEATE (SIGMAPHARM LABS LLC) APPROVAL= AP YEAR= 2020 NDA 205960 (pdf not found) INN (ASENAPINE MALEATE) ASENAPINE MALEATE (BRECKENRIDGE) APPROVAL= AP YEAR= 2020 |
Other links: |